Making CAR T Cells a Solid Option for Solid Tumors

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.02593
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies

Frontiers in Immunology
AllergyImmunology
2018English

394. McSP-Chimeric Antigen Receptor (CAR)-Redirected T Cells Target Multiple Solid Tumors

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2013English

CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment

Frontiers in Immunology
AllergyImmunology
2019English

Hurdles of CAR-T Cell-Based Cancer Immunotherapy Directed Against Solid Tumors

Science China Life Sciences
GeneticsMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesAgricultural
2016English

CAR-T Cells With Co-Expressed Cytokines and Chemokines Better Overcome Inhibitory Microenvironment of Solid Tumors

Clinical Research and Trials
2019English

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Cancer Discovery
Oncology
2015English

Adoptive T-Cell Therapy for Solid Tumors

American Society of Clinical Oncology educational book / ASCO. American Society of Clinical Oncology. Meeting
Medicine
2017English

Targeting High-Risk Pediatric Solid Tumors With CAR T Cells Directed Against ALK (Anaplastic Lymphoma Kinase, CD246)

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy